Alonza L. Clark

Alonza L. Clark serves as a Purchasing Agent for the Defense Health Agency, where she plays a critical role in acquiring essential medical equipment and technology to support operational readiness across the global Department of Defense healthcare network. Her responsibilities include managing the full lifecycle of procurement actions—from market research and solicitation to contract award and administration—for high-value clinical and diagnostic systems. She specializes in sourcing electromedical and surgical instrumentation critical to battlefield medicine, hospital operations, and long-term patient care, ensuring compliance with federal acquisition regulations and DOD-specific standards for medical device safety and interoperability. Clark maintains consistent working relationships with a select group of specialized vendors, including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a focus on suppliers with proven expertise in medical device manufacturing, biomedical technology integration, and secure health data handling. Her procurement approach prioritizes reliability, regulatory compliance, and technical precision, often engaging contractors with FDA-cleared or CE-marked products aligned with DHA’s clinical standards. Clark’s procurement activity is exclusively conducted under open competition, with no set-asides applied to her acquisitions. This reflects a strategic emphasis on technical capability and mission-critical performance over socioeconomic preferences, aligning with DHA’s need for rapid, scalable, and vetted medical solutions across diverse operational environments. Her primary procurement focus lies in NAICS 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing) and 339112 (Surgical and Medical Instrument Manufacturing), indicating deep expertise in acquiring advanced diagnostic tools, surgical devices, patient monitoring systems, and life-support equipment. She consistently sources products requiring stringent quality controls, clinical validation, and cybersecurity compliance, underscoring her technical fluency in the medical technology domain.